Stage IVB Colorectal Cancer Terminated Phase 2 Trials for Panitumumab (DB01269)

IndicationStatusPhase
DBCOND0068497 (Stage IVB Colorectal Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02508077FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal CancerTreatment